Eliza M Mace

Title: Eliza M Mace: Innovator in CRISPR Technology

Introduction

Eliza M Mace is a prominent inventor based in McLean, VA (US). She has made significant contributions to the field of genetic engineering, particularly in the area of CRISPR technology. Her innovative work has the potential to advance our understanding of genome editing and its implications.

Latest Patents

Eliza M Mace holds a patent for "Systems and methods for detecting CRISPR-mediated residues within methylated patterns of genome using a convolutional neural network." This patent describes a system, method, and computer-readable medium for detecting a CRISPR-edited genome. The system includes processors that receive sequence data of a genome, generate an image representation of the sequenced data, and apply this representation to a trained convolutional neural network (CNN). The CNN generates a score indicative of the probability that the genome was CRISPR-edited, allowing for the determination of whether the genome contains a CRISPR-edited methylation region.

Career Highlights

Eliza M Mace has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with The Mitre Corporation, where she continues to explore advancements in genetic technologies. Her work is characterized by a commitment to pushing the boundaries of what is possible in genome editing.

Collaborations

Eliza has collaborated with notable colleagues, including Heath Farris and Tyrone V Patterson, III. These collaborations have further enriched her research and contributed to the advancement of CRISPR technology.

Conclusion

Eliza M Mace is a trailblazer in the realm of CRISPR technology, with her innovative patent showcasing her expertise and dedication to advancing genetic research. Her contributions are paving the way for future developments in the field.